These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 35234774)

  • 1. Emerging nanotechnologies for targeting antimicrobial resistance.
    Weldick PJ; Wang A; Halbus AF; Paunov VN
    Nanoscale; 2022 Mar; 14(11):4018-4041. PubMed ID: 35234774
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nanotechnology for Targeted Detection and Removal of Bacteria: Opportunities and Challenges.
    Hajipour MJ; Saei AA; Walker ED; Conley B; Omidi Y; Lee KB; Mahmoudi M
    Adv Sci (Weinh); 2021 Nov; 8(21):e2100556. PubMed ID: 34558234
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanotechnologies for control of pathogenic microbial biofilms.
    Asare EO; Mun EA; Marsili E; Paunov VN
    J Mater Chem B; 2022 Jul; 10(27):5129-5153. PubMed ID: 35735175
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nanomaterial in controlling biofilms and virulence of microbial pathogens.
    Tungare K; Gupta J; Bhori M; Garse S; Kadam A; Jha P; Jobby R; Amanullah M; Vijayakumar S
    Microb Pathog; 2024 Jul; 192():106722. PubMed ID: 38815775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Targeting pathogenic fungi, bacteria and fungal-bacterial biofilms by newly synthesized quaternary ammonium derivative of pyridoxine and terbinafine with dual action profile.
    Garipov MR; Sabirova AE; Pavelyev RS; Shtyrlin NV; Lisovskaya SA; Bondar OV; Laikov AV; Romanova JG; Bogachev MI; Kayumov AR; Shtyrlin YG
    Bioorg Chem; 2020 Nov; 104():104306. PubMed ID: 33011535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nanotechnology Approaches for Rapid Detection and Theranostics of Antimicrobial Resistant Bacterial Infections.
    Saxena S; Punjabi K; Ahamad N; Singh S; Bendale P; Banerjee R
    ACS Biomater Sci Eng; 2022 Jun; 8(6):2232-2257. PubMed ID: 35546526
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention and treatment of biofilms by hybrid- and nanotechnologies.
    Kasimanickam RK; Ranjan A; Asokan GV; Kasimanickam VR; Kastelic JP
    Int J Nanomedicine; 2013; 8():2809-19. PubMed ID: 23946652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metal and Metal Oxide Nanoparticle as a Novel Antibiotic Carrier for the Direct Delivery of Antibiotics.
    Kotrange H; Najda A; Bains A; Gruszecki R; Chawla P; Tosif MM
    Int J Mol Sci; 2021 Sep; 22(17):. PubMed ID: 34502504
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Recent nanotechnology-based strategies for interfering with the life cycle of bacterial biofilms.
    Wu J; Zhang B; Lin N; Gao J
    Biomater Sci; 2023 Feb; 11(5):1648-1664. PubMed ID: 36723075
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibiotic resistance.
    Frieri M; Kumar K; Boutin A
    J Infect Public Health; 2017; 10(4):369-378. PubMed ID: 27616769
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial resistance to nanotechnologies: An important but understudied consideration using antimicrobial nanotechnologies in orthopaedic implants.
    Wu Z; Chan B; Low J; Chu JJH; Hey HWD; Tay A
    Bioact Mater; 2022 Oct; 16():249-270. PubMed ID: 35415290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ameliorating the antimicrobial resistance crisis: phage therapy.
    Saha D; Mukherjee R
    IUBMB Life; 2019 Jul; 71(7):781-790. PubMed ID: 30674079
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promising Therapeutic Strategies Against Microbial Biofilm Challenges.
    Zhang K; Li X; Yu C; Wang Y
    Front Cell Infect Microbiol; 2020; 10():359. PubMed ID: 32850471
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Novel approaches to combat bacterial biofilms.
    Beloin C; Renard S; Ghigo JM; Lebeaux D
    Curr Opin Pharmacol; 2014 Oct; 18():61-8. PubMed ID: 25254624
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protocols for Studying Inhibition and Eradication of Bacterial Biofilms by Antimicrobial Peptides.
    Sarojini V
    Methods Mol Biol; 2017; 1548():323-330. PubMed ID: 28013515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipid Nanocarriers-Enabled Delivery of Antibiotics and Antimicrobial Adjuvants to Overcome Bacterial Biofilms.
    Ahsan A; Thomas N; Barnes TJ; Subramaniam S; Loh TC; Joyce P; Prestidge CA
    Pharmaceutics; 2024 Mar; 16(3):. PubMed ID: 38543290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antimicrobial management of complicated skin and skin structure infections in the era of emerging resistance.
    Lee SY; Kuti JL; Nicolau DP
    Surg Infect (Larchmt); 2005; 6(3):283-95. PubMed ID: 16201938
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nanobiotics and the One Health Approach: Boosting the Fight against Antimicrobial Resistance at the Nanoscale.
    Himanshu ; Mukherjee R; Vidic J; Leal E; da Costa AC; Prudencio CR; Raj VS; Chang CM; Pandey RP
    Biomolecules; 2023 Jul; 13(8):. PubMed ID: 37627247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of Antimicrobial Resistance (AMR) and Alternative Approaches to Overcome AMR.
    Moo CL; Yang SK; Yusoff K; Ajat M; Thomas W; Abushelaibi A; Lim SH; Lai KS
    Curr Drug Discov Technol; 2020; 17(4):430-447. PubMed ID: 30836923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bacterial metal nanoparticles to develop new weapons against bacterial biofilms and infections.
    Gallo G; Schillaci D
    Appl Microbiol Biotechnol; 2021 Jul; 105(13):5357-5366. PubMed ID: 34184105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.